Publications by authors named "Johnathan M Lancaster"

Claim this Profile
P
Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.
Sharon E Robertson, Maya Yasukawa, Douglas C Marchion, Yin Xiong, Syeda Mahrukh Hussnain Naqvi, Johnathan M Lancaster

PLoS One· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.
David Stein, Ernesto Oviedo-Orta, Wendy A Kampman, Jennifer McGinniss, George Betts, Johnathan M Lancaster

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
Elisha Hughes, Placede Tshiaba, Susanne Wagner, Thaddeus Judkins, Eric Rosenthal, Johnathan M Lancaster

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
Daryoush Saeed-Vafa, Douglas C Marchion, Susan M McCarthy, Ardeshir Hakam, Alexis Lopez, Johnathan M Lancaster

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated () Gene are Associated with High and Moderate Risks for Multiple Cancers.
Michael J Hall, Ryan Bernhisel, Elisha Hughes, Katie Larson, Eric T Rosenthal, Johnathan M Lancaster

Cancer Prev Res (Phila)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing.
Shelly Cummings, Susana San Roman, Jennifer Saam, Ryan Bernhisel, Krystal Brown, Johnathan M Lancaster

J Ovarian Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of multigene panel testing for hereditary breast and ovarian cancer.
Stacey Dacosta Byfield, Helen Wei, Mary DuCharme, Johnathan M Lancaster

J Comp Eff Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.
Gregory S Calip, John Kidd, Ryan Bernhisel, Hannah C Cox, Jennifer Saam, Johnathan M Lancaster

Breast Cancer Res Treat· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Hatem Soliman, Susanne Wagner, Darl D Flake, Mark Robson, Lee Schwartzberg, Johnathan M Lancaster

Ann Surg Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor.
Malek B Hannouf, Dale Muzzey, Ralf Kronenwett, Johnathan M Lancaster

J Comp Eff Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Bernadette M Boac, Forough Abbasi, Roohi Ismail-Khan, Yin Xiong, Atif Siddique, Johnathan M Lancaster

Sci Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Distant Recurrence Using EndoPredict Among Women with ER, HER2 Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Martin Filipits, Peter Dubsky, Margaretha Rudas, Richard Greil, Marija Balic, Johnathan M Lancaster

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk.
Gregory E Idos, Allison W Kurian, Charité Ricker, Duveen Sturgeon, Julie O Culver, Johnathan M Lancaster

JCO Precis Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.
Bernadette M Boac, Yin Xiong, Sachin M Apte, Robert M Wenham, Mian M Shahzad, Johnathan M Lancaster

Am J Obstet Gynecol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center.
Patricia L Judson, Reem Abdallah, Yin Xiong, Judith Ebbert, Johnathan M Lancaster

Integr Cancer Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Payer Constraints on Access to Genetic Testing.
Pat Whitworth, Peter Beitsch, Christopher Arnell, Hannah C Cox, Krystal Brown, Johnathan M Lancaster

J Oncol Pract· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT health.
Gina Shetty, Julian A Sanchez, Johnathan M Lancaster, Lauren E Wilson, Gwendolyn P Quinn

Patient Educ Couns· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.
Cheng-Xiong Xu, Meng Xu, Lei Tan, Hua Yang, Jennifer Permuth-Wey, Johnathan M Lancaster

J Biol Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.
Stephen H Bush, Sharon Tollin, Douglas C Marchion, Yin Xiong, Forough Abbasi, Johnathan M Lancaster

Mol Clin Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
Jennifer Permuth-Wey, William J Fulp, Brett M Reid, Zhihua Chen, Christina Georgeades, Johnathan M Lancaster

Int J Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.
Bernadette M Boac, Yin Xiong, Douglas C Marchion, Forough Abbasi, Stephen H Bush, Johnathan M Lancaster

Gynecol Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.
Nadim Bou Zgheib, Douglas C Marchion, Stephen H Bush, Patricia L Judson, Robert M Wenham, Johnathan M Lancaster

Oncol Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center.
Reem Abdallah, Yin Xiong, Johnathan M Lancaster, Patricia L Judson

Int J Gynecol Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data.
Reem Abdallah, Hye Sook Chon, Nadim Bou Zgheib, Douglas C Marchion, Robert M Wenham, Johnathan M Lancaster

Int J Gynecol Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAD-mediated apoptotic pathway is associated with human cancer development.
Xiaomang B Stickles, Douglas C Marchion, Elona Bicaku, Entidhar Al Sawah, Forough Abbasi, Johnathan M Lancaster

Int J Mol Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis